News & Updates

To Learn more about the news at the Chornic Traumatic Encephalopathy Center Click HERE.

Development Project Grants – Request for applications (Deadline January 11th, 2019)

By Christina DiTerlizzi
November 13th, 2018 in News.

Development Project Grants Request for applications Alzheimer’s Disease Development Grants The Boston University Alzheimer’s Disease Core Center (BU ADC) Is Soliciting Proposals for Pilot and Feasibility Studies Application Deadline: January 11th, 2019 New proposals or initiatives for biomedical, epidemiological behavioral, legal, ethical, health systems or other research in Alzheimer’s disease are encouraged.  Two NIH funded... More

Did you know that November is Alzheimer’s Disease and Family Caregivers Month?

By Christina DiTerlizzi
November 6th, 2018 in News.

In 1983, President Ronald Reagan was the first president to designate November as National Alzheimer's Disease Awareness Month, while President Bill Clinton first designated November as National Family Caregivers Month in 1997. More

BU CTE Center researchers have identified a gene linked to CTE-related outcomes

By Christina DiTerlizzi
November 5th, 2018 in News, Research Updates.

After 10 years of studying brains donated by families of deceased military servicepeople, football players, and other contact-sport athletes, researchers from the BU School of Medicine and the VA Boston Healthcare System have amassed more than 600 brains, a collection they say has grown large enough to enable meaningful analysis... More

Congratulations Dr. Ann McKee, Director of the VA-BU-CLF Brain Bank for being elected to the National Academy of Medicine.

By Christina DiTerlizzi
November 2nd, 2018 in News.

NAM is made up of more than 2,000 international members elected by their peers, for outstanding achievements in medicine. More

Dr. Ann McKee & her team awarded a new grant to study novel biomarkers in CTE and other diseases.

By Christina DiTerlizzi
November 1st, 2018 in News, Research Updates.

The goal of this study is to identify novel biomarkers to distinguish CTE, PART, AGD, ARTAG, and AD. More